how many people are on semaglutide Statistics 2026: Ozempic & Wegovy Data, Clinical Outcomes & Market Trends | GoalBMI Semaglutide, also known as Ozempic,

Presented for research literature review only Passeri M et al

These medications, known as GLP-1 receptor agonists, were originally developed to help people with type 2 diabetes manage their blood sugar

For the time that patients spend on these drugs and after, we are already developing a number of companion products

Klausen et al 37 reported adverse effects related to GI symptoms, body weight loss, fatigue, and injection site reactions, and the incidence was higher in the exenatide group compared with the placebo group

Exenatide Overview : Exenatide, like semaglutide, is a GLP-1 receptor agonist used for diabetes management Pros : Effective for blood sugar control and potential weight loss Cons : Requires injections, and it may have side effects 5